SDZ MRL 953, a novel immunostimulatory monosaccharidic lipid A analog with an improved therapeutic window in experimental sepsis.

SDZ MRL 953, a new synthetic monosaccharidic lipid A, was investigated in vitro and in vivo for immunopharmacological activities. In experimental models of microbial infections, the compound was highly protective when it was administered prophylactically either once or three times to myelosuppressed...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	Antimicrob Agents Chemother
Hauptverfasser:	Lam, C, Schütze, E, Hildebrandt, J, Aschauer, H, Liehl, E, Macher, I, Stütz, P
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	American Society for Microbiology (ASM) 1991
Schlagworte:	Research Article
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC245039/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2039200/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.35.3.500
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!